Neoantigen Cancer Vaccine market, By Product (Personalized and Off-the-shelf), By Type, By Route of Administration, By Delivery Mechanism, By Application, By Country, and By Region - Industry Analysis, market Size, market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
The Neoantigen Cancer Vaccine Market size was valued at USD 46,059.43 million in 2023, expanding at a CAGR of 73.40% from 2024 to 2032.
Neoantigen cancer vaccines constitute a form of personalized immunotherapy aimed at activating the immune system to identify and combat cancerous cells. These vaccines focus on neoantigens, which are unique antigens generated from mutations within tumor cells. The development of neoantigen cancer vaccines marks a notable progression in the field of cancer immunotherapy, utilizing the distinct features of an individual’s tumor to bolster the body’s inherent capacity to combat cancer.
Neoantigen Cancer Vaccine Market- Market Dynamics
The growing adoption of personalized medicine aimed at customizing patient treatment is anticipated to propel market expansion. This approach emphasizes the development of treatment plans that are specifically designed to align with individual patient characteristics, such as genetic profiles, tumor features, and overall health status. Central to this methodology are Neoantigen vaccines, which are meticulously crafted based on the distinct mutations found in a patient\'s tumor. Notably, the number of personalized medicines available in the market increased from 132 to 286, with these therapies representing 25% of the new drugs approved by the FDA in 2019.
Moreover, enhanced funding from both public and private sectors, including contributions from pharmaceutical companies and venture capitalists, is driving research and development efforts in this domain. Nevertheless, the complexity of manufacturing processes may pose challenges to market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEOANTIGEN CANCER VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
OSE Immunotherapeutics SA
Gritstone Bio Inc.
BioNTech SE
Hoffmann-La Roche Ltd.
Pfizer Inc.
Merck & Co. Inc.
Moderna Inc.
Avidea Technologies Inc.
Eli Lilly and Company
Vaccibody AS
Agenus Inc.
Novogene Co. Ltd.
ZIOPHARM Oncology Inc.
ISA Pharmaceuticals B.V.
BrightPath Biotherapeutics Co. Ltd.
Vaximm AG
Medigene AG
Genocea Biosciences Inc.
Advaxis Inc.
Nouscom AG
Others
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Personalized
Off-the-shelf
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Dendritic Cell
Nucleic Acid
Synthetic Long Peptide
Tumor Cell
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Intramuscular
Intravenous
Transdermal
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY DELIVERY MECHANISM- MARKET ANALYSIS, 2019 - 2032
Liposomes
Virosomes
Gene gun
Electroporation
Others
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Brain Cancer
Gastrointestinal Cancer
Lung Cancer
Melanoma
Others
GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Neoantigen Cancer Vaccine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Neoantigen Cancer Vaccine Market Snippet by Product
2.1.2. Neoantigen Cancer Vaccine Market Snippet by Type
2.1.3. Neoantigen Cancer Vaccine Market Snippet by Route of Administration
2.1.4. Neoantigen Cancer Vaccine Market Snippet by Delivery Mechanism
2.1.5. Neoantigen Cancer Vaccine Market Snippet by Application
2.1.6. Neoantigen Cancer Vaccine Market Snippet by Country
2.1.7. Neoantigen Cancer Vaccine Market Snippet by Region
2.2. Competitive Insights
3. Neoantigen Cancer Vaccine Key Market Trends
3.1. Neoantigen Cancer Vaccine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Neoantigen Cancer Vaccine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Neoantigen Cancer Vaccine Market Opportunities
3.4. Neoantigen Cancer Vaccine Market Future Trends
4. Neoantigen Cancer Vaccine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Neoantigen Cancer Vaccine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Neoantigen Cancer Vaccine Market Landscape
6.1. Neoantigen Cancer Vaccine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Neoantigen Cancer Vaccine Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
7.1.2. Personalized
7.1.3. Off-the-shelf
8. Neoantigen Cancer Vaccine Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
8.1.2. Dendritic Cell
8.1.3. Nucleic Acid
8.1.4. Synthetic Long Peptide
8.1.5. Tumor Cell
9. Neoantigen Cancer Vaccine Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
9.1.2. Intramuscular
9.1.3. Intravenous
9.1.4. Transdermal
10. Neoantigen Cancer Vaccine Market – By Delivery Mechanism
10.1. Overview
10.1.1. Segment Share Analysis, By Delivery Mechanism, 2023 & 2032 (%)
10.1.2. Liposomes
10.1.3. Virosomes
10.1.4. Gene gun
10.1.5. Electroporation
10.1.6. Others
11. Neoantigen Cancer Vaccine Market – By Application
11.1. Overview
11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
11.1.2. Brain Cancer
11.1.3. Gastrointestinal Cancer
11.1.4. Lung Cancer
11.1.5. Melanoma
11.1.6. Others
12. Neoantigen Cancer Vaccine Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Neoantigen Cancer Vaccine Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Neoantigen Cancer Vaccine Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Neoantigen Cancer Vaccine Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Neoantigen Cancer Vaccine Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Neoantigen Cancer Vaccine Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Neoantigen Cancer Vaccine Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. OSE Immunotherapeutics SA
13.2.2. Gritstone bio Inc.
13.2.3. BioNTech SE
13.2.4. Hoffmann-La Roche Ltd.
13.2.5. Pfizer Inc.
13.2.6. Merck & Co. Inc.
13.2.7. Moderna Inc.
13.2.8. Avidea Technologies Inc.
13.2.9. Eli Lilly and Company
13.2.10. Vaccibody AS
13.2.11. Agenus Inc.
13.2.12. Novogene Co. Ltd.
13.2.13. ZIOPHARM Oncology Inc.
13.2.14. ISA Pharmaceuticals B.V.
13.2.15. BrightPath Biotherapeutics Co. Ltd.
13.2.16. Vaximm AG
13.2.17. Medigene AG
13.2.18. Genocea Biosciences Inc.
13.2.19. Advaxis Inc.
13.2.20. Nouscom AG
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
